Johnson & Johnson can't get $70M Risperdal verdict tossed at Pennsylvania appeals court

26th November 2019 Uncategorised 0

A Pennsylvania appeals court upheld a 2016 verdict against J&J worth $70 million. The case stems back to a 2013 lawsuit from Andrew Yount and his mother alleging the company’s Risperdal caused him to develop breasts, a condition called gynecomastia. The court sent the case back to a lower court to consider punitive damages.

More: Johnson & Johnson can't get M Risperdal verdict tossed at Pennsylvania appeals court
Source: fierce